Transfusion Medicine impacts patients with hematologic, oncologic, and surgical conditions as well as all areas of critical care medicine and multiple areas of chronic care. This book aims to be the single best source for information related to any aspect or application of Transfusion Medicine.

Contributors for the sixth edition have once again been drawn from various scientific, medical, and surgical disciplines. Thus, this book ranges from encouraging and managing donors, to collecting and preserving the blood, to matching it to the appropriate recipient, all the way to its clinical uses. It also extends these concepts to implantable tissue and regenerative medicine. Other sample topics covered within the work include:

• Contemporary issues in donation and transfusion: patient blood management, clinical and technical aspects of blood administration, and donor and patient Hemovigilance
• Blood components and derivatives: red blood cell metabolism, preservation and oxygen delivery, blood groups, and composition of plasma
• Apheresis, transplantation, and new therapies: hematopoietic growth factors, therapeutic phlebotomy and cellular apheresis, HLA antigens, alleles, and antibodies
• How Transfusion Medicine has been affected by the coronavirus pandemic, the role of pathogen reduction and other modern trends

This book serves as a complete and comprehensive resource on Transfusion Medicine for clinicians who prescribe blood, students who expect to enter clinical practice, and for the scientists, physicians, nurses, technologists, and others who assure the quality and availability of blood services.

Toby L. Simon, MD is Senior Medical Director for Plasma and Plasma Safety with CSL Plasma and in Research and Development for the parent company CSL Behring, He is past-president of AABB and America’s Blood Centers. He has been on the faculty of University of New Mexico School of Medicine (currently clinical faculty), Medical Director of TriCore Reference Laboratories and industry representative to the FDA Blood Products Advisory Committee.

Eric A. Gehrie, MD is a clinical pathologist who specializes in blood banking/transfusion medicine. He is currently the Executive Physician Director over Direct Patient Care and Emerging Cell and Gene Therapy Solutions at the American Red Cross. He has previously been on the faculty of both Yale and Johns Hopkins University Schools of Medicine. He is a member of the editorial board of Transfusion.

Jeffrey McCullough, MD is Professor Emeritus at the University of Minnesota Medical School with experience in both hospital transfusion services and blood centers. He was the editor of Transfusion for 15 years and the founding president of the US National Marrow Donor Program. He is currently an international advisor in transfusion medicine. He is past-president of the American Board of Pathology.

John D. Roback, MD, PhD is a Professor in the Department of Pathology and Laboratory Medicine at Emory University. His appointments include Medical Director of Emory Medical Laboratories, Emory/Children’s Laboratory for Innovative Assay Development, and the Center for Transfusion and Cellular Therapies. He is also Executive Vice-Chair of Clinical Operations. He is a former editor of the AABB Technical Manual.

Edward L. Snyder, MD, FACP is Professor of Laboratory Medicine and Attending Physician in the Transfusion and Tissue Services at Yale Medical School/Yale New Haven Hospital. He is also the blood bank director at Bridgeport Hospital. He is past chair of the BeTheMatch Board of Directors and is a past-president of AABB. He is an associate editor of Transfusion and past-recipient of Emily Cooley, Morton Grove-Rasmussen and presidential awards from AABB.